Skip to main content
Haisco Pharmaceutical Group Co.,Ltd logo

Haisco Pharmaceutical Group Co.,Ltd — Investor Relations & Filings

Ticker · 002653 ISIN · CNE100001BC7 LEI · 300300GRLH34A8GPJ639 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,439 across all filing types
Latest filing 2023-11-17 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002653

About Haisco Pharmaceutical Group Co.,Ltd

https://www.haisco.com

Haisco Pharmaceutical Group Co.,Ltd. focuses on the research, development, production, and commercialization of innovative drugs and high-end generic pharmaceuticals. The company maintains a specialized portfolio across therapeutic areas including anesthesia, parenteral nutrition, anti-infection, cardiovascular health, and endocrine disorders. Key products include advanced anesthetic agents and specialized nutritional injections designed for clinical use. Haisco prioritizes technological innovation through a dedicated R&D infrastructure, targeting the development of small molecule chemical drugs and complex delivery systems. Its operations emphasize high-standard manufacturing processes and the integration of clinical research to address complex medical requirements. The company aims to provide therapeutic solutions that enhance patient care through a commitment to scientific excellence and product quality.

Recent filings

Filing Released Lang Actions
关于控股股东部分股份质押的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the pledge of shares by a controlling shareholder of the company. It details the number of shares pledged, the proportion of total shares, pledge start and end dates, and the pledgee. There is no financial data, earnings information, or management discussion. The document is a regulatory announcement about share pledging, which fits the category of a Regulatory Filing (RNS) as it does not fit into more specific categories like Capital/Financing Update or Major Shareholding Notification, since it focuses on share pledge rather than ownership change or capital raising.
2023-11-17 Chinese
关于对控股子公司减资暨关联交易的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress of a capital reduction and related party transaction involving a controlling subsidiary of the company. It details the approval of the transaction by the board, the reduction of capital, and the completion of the transaction. The document is short (701 characters) and focuses on a specific corporate action related to capital structure changes. It is not a full financial report, audit, or earnings release. It is not a notice of dividend or voting results. The content fits best under Capital/Financing Update (CAP) as it concerns a capital reduction and related transaction progress.
2023-11-14 Chinese
独立董事关于第五届董事会第四次会议相关事项的事前认可意见和独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's pre-approval and independent opinion regarding a related-party transaction involving capital reduction of a controlling subsidiary. It references compliance with stock exchange listing rules and company articles, and discusses the fairness and procedural correctness of the transaction. The content is focused on board-level governance and approval of a specific corporate action, not a full financial report or earnings release. It is not a report publication announcement or certification letter but a governance-related document. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of board decisions and management matters.
2023-11-10 Chinese
关于高级管理人员辞职的公告
Board/Management Information Classification · 100% confidence The document is a short announcement regarding the resignation of a senior management person (the company's vice general manager). It contains no financial data, no report or presentation, and is focused solely on management change. The document length is only 530 characters, indicating it is a brief announcement. According to the definitions, announcements about changes in senior management fall under 'Board/Management Information' (MANG).
2023-11-10 Chinese
关于对控股子公司减资暨关联交易的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding a capital reduction transaction involving the company's wholly-owned subsidiary and related parties. It details the background, financial data, approval process, and independent opinions related to the transaction. The document is relatively short (3850 characters) and focuses on a specific corporate action involving capital structure changes and related party transactions. It does not contain comprehensive financial statements or detailed financial performance data typical of annual or interim reports. It is not a full audit report, earnings release, or management discussion. The content aligns with announcements about capital structure changes and related party transactions, which fits the category of Capital/Financing Update (CAP).
2023-11-10 Chinese
华泰联合证券有限责任公司关于海思科医药集团股份有限公司对控股子公司减资暨关联交易的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed review and verification opinion from Huatai United Securities regarding a related-party transaction involving capital reduction of a controlling subsidiary by Haisco Pharmaceutical Group. It includes detailed descriptions of the transaction, parties involved, financial data, board approvals, and independent opinions. The document is not a financial report like an annual or interim report, nor is it a simple announcement or certification. It is a specialized audit or verification report related to a specific transaction and compliance with regulatory and governance requirements. Therefore, it fits best under the category of Audit Report / Information (AR). The document length is under 5,000 characters but contains substantive content and detailed analysis, not just an announcement or certification, so it is not RPA or RNS. 9M 2023
2023-11-10 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.